| Datopotamab Deruxtecan investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 22show all (up to 200) |
|---|
| → investigated in trials for | Lung Non-Small Cell Carcinomasubtype 23 trials (21 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Lung Non-Small Cell Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Breast Neoplasmcancer_family 15 trials (15 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Breast Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Triple-Negative Breast Carcinomamolecular_subtype 6 trials (6 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Triple-Negative Breast Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Breast Neoplasmcancer_family 2 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Breast Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Bladder Neoplasm 2 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Bladder Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Colorectal Neoplasm 2 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Colorectal Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Endometrial Neoplasm 2 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Endometrial Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Gastric Neoplasm 2 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Gastric Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Lung Neoplasm 2 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Lung Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Ovarian Neoplasm 2 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Ovarian Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Solid Neoplasm 2 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Solid Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Angiosarcomasubtype 1 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Castration-Resistant Prostate Carcinoma 1 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Early Stage Breast Carcinoma 1 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Early Stage Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HER2-Low Breast Carcinoma 1 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | HER2-Low Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |